Amerisourcebergen Drug's annual revenues are over $500 million (see exact revenue data) and has over 1,000 employees. It is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry.
Note: Amerisourcebergen Drug's revenues are gauged from an analysis of company filings.
Amerisourcebergen Drug has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
February 28, 2014
Complete list of funding rounds and total amounts in the Company Report
Trademark applications show the products and services that Amerisourcebergen Drug is developing and marketing.
Amerisourcebergen Drug's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
PHARMOJI Downloadable computer software applications which allow users to create virtual images consisting of avatars, graphic icons, symbols, images representing individuals, text, and graphical depictions of people, places and things that can be posted, shared and transmitted via email, multi-media messaging (MMS), text messaging (SMS), online chatrooms, global computer networks, and other telecommunications networks
GOOD NEIGHBOR SCRIPT Downloadable periodic electronic publications in the nature of informational flyers featuring health and wellness topics
BELLCOGENERICS Wholesale distributorship services featuring prescription pharmaceuticals, non-prescription over-the-counter (OTC) drugs, medical and surgical supplies, healthcare and beauty aid products
Determine whether Amerisourcebergen Drug grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Amerisourcebergen Drug is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Amerisourcebergen Drug's Largest Competitors
A competitive analysis shows these companies are in the same general field as Amerisourcebergen Drug, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Amerisourcebergen Drug.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Amerisourcebergen Drug and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.